Authors:
Schito, ML
Kennedy, PE
Kowal, RP
Berger, EA
Sher, A
Citation: Ml. Schito et al., A human immunodeficiency virus-transgenic mouse model for assessing interventions that block microbial-induced proviral expression, J INFEC DIS, 183(11), 2001, pp. 1592-1600
Citation: K. Salzwedel et Ea. Berger, Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: Functional complementation of specific defects in gp120 and gp41, P NAS US, 97(23), 2000, pp. 12794-12799
Authors:
Dey, B
Lerner, DL
Lusso, P
Boyd, MR
Elder, JH
Berger, EA
Citation: B. Dey et al., Multiple antiviral activities of cyanovirin-N: Blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses, J VIROLOGY, 74(10), 2000, pp. 4562-4569
Citation: K. Salzwedel et al., Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: Soluble CD4 activates Env for coreceptor-dependent fusionand reveals blocking activities of antibodies against cryptic conserved epitopes on gp120, J VIROLOGY, 74(1), 2000, pp. 326-333
Authors:
Goldstein, H
Pettoello-Mantovani, M
Bera, TK
Pastan, IH
Berger, EA
Citation: H. Goldstein et al., Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy/liv-SCID-Hu mice, J INFEC DIS, 181(3), 2000, pp. 921-926
Citation: Ea. Berger et al., Reconsidering targeted toxins to eliminate HIV infection: You gotta have HAART (vol 95, pg 11511, 1998), P NAS US, 96(3), 1999, pp. 1162-1162
Authors:
Esser, MT
Mori, T
Mondor, I
Sattentau, QJ
Dey, B
Berger, EA
Boyd, MR
Lifson, JD
Citation: Mt. Esser et al., Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120, J VIROLOGY, 73(5), 1999, pp. 4360-4371